XENETIC BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.956 USD | +4.09% |
|
+0.78% | +14.65% |
Chart calendar Xenetic Biosciences, Inc.
e2cb.A7Tnh_bcMYDDZ_uHWk_QO3-V05lBJMDOTUlDej7S5RQ.Uv2s9cKRRvGoFajiHX7oQw7c5t1sYLS9PH4WLFaXp0REwJTit6959JITtg~277717456481b47f6a875800cb30963d
Upcoming events on Xenetic Biosciences, Inc.
Past events on Xenetic Biosciences, Inc.
| 2024-05-10 08:30 am | Q1 2024 Earnings Release |
| 2023-12-06 10:00 am | Annual General Meeting |
| 2023-11-10 08:35 am | Q3 2023 Earnings Release |
| 2023-10-24 01:00 pm | Virtual Investor Ask the CEO Conference |
| 2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
| 2023-08-11 08:05 am | Q2 2023 Earnings Release |
| 2023-07-12 10:00 am | Virtual Investor Summer Spotlight Conference |
| 2023-03-29 11:00 am | Virtual Investor NETs in Cancer Spotlight Conference |
| 2023-03-23 07:35 am | Q4 2022 Earnings Release |
| 2023-01-17 10:00 am | Virtual Investor Conference |
| 2022-11-10 07:05 am | Q3 2022 Earnings Release |
| 2022-09-12 07:00 am | H.C. Wainwright Global Investment Conference |
| 2022-08-11 | Interim 2022 Earnings Release |
| 2022-06-09 11:00 am | Investor Innovation in Oncology Event |
| 2022-05-25 04:00 pm | H.C. Wainwright Global Life Sciences Investment Conference |
| 2022-05-12 04:05 pm | Q1 2022 Earnings Release |
| 2022-04-27 08:30 am | DNase Based Oncology Platform Licensing Update Call |
| 2022-03-23 08:30 am | FY 2021 Earnings Release |
| 2022-01-25 10:00 am | JTC Team Virtual Investor Top Picks Conference |
| 2021-12-07 10:00 am | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 0,01 0,00 - | 0,31 0,31 1.81% | 0,88 | 1,40 1,20 16.2% | 2,00 2,12 -5.3% | 1,76 |
|
EBITDA Million GBP | Released Forecast Spread | 0,00 0,00 - | -10,0 -10,4 3.95% | -4,34 | -5,49 -5,83 5.82% | -3,56 -3,83 6.86% | -4,80 |
|
EBIT Million GBP | Released Forecast Spread | -10,6 -10,0 -6.05% | -10,0 -10,6 5.59% | -4,34 | -5,49 -5,83 5.82% | -3,56 -3,83 6.86% | -4,80 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -10,5 -9,97 -5.52% | -9,95 -10,6 5.76% | -4,26 | -5,36 -5,58 3.91% | -3,26 -3,50 6.78% | -4,56 |
|
Net income Million GBP | Released Forecast Spread | -14,9 -9,97 -49.17% | -7,84 -8,34 5.89% | -4,26 | -5,36 -5,58 3.91% | -3,26 -3,50 6.78% | -4,56 |
|
EPS USD | Released Forecast Spread | -63,3 -55,6 -13.85% | -17,0 -16,0 -6.25% | -5,50 | -4,60 -4,50 -2.22% | -2,71 -2,82 3.9% | -0,96 |
| Announcement Date | 26/03/20 | 16/03/21 | 22/03/22 | 22/03/23 | 21/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 0,32 0,27 16.94% | 0,34 0,28 22.74% | 0,36 0,29 26.48% | 0,40 0,15 158.53% | 0,48 0,34 44.53% | 0,51 0,35 45.28% | 0,50 0,37 35.22% | 0,53 0,55 -4.26% | 0,41 0,51 -20.43% | 0,43 | 0,46 | 0,48 |
|
EBITDA Million GBP | Released Forecast Spread | -1,32 -1,28 -3.55% | -2,20 -1,47 -49.58% | -0,74 -2,29 67.6% | -1,28 -1,46 12.33% | -0,73 -1,55 52.91% | -0,94 -1,44 34.55% | -0,93 -1,52 38.5% | -0,99 -1,22 18.83% | -1,01 -1,11 8.77% | -1,12 | -1,28 | -1,44 |
|
EBIT Million GBP | Released Forecast Spread | -1,32 -1,28 -3.55% | -2,20 -1,47 -49.58% | -0,74 -2,29 67.6% | -1,28 -1,46 12.33% | -0,73 -1,55 52.91% | -0,94 -1,44 34.55% | -0,93 -1,52 38.5% | -0,99 -1,22 18.83% | -1,01 -1,11 8.77% | -1,12 | -1,28 | -1,44 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -1,30 -1,20 -8.68% | -2,19 -1,39 -57.53% | -0,70 -2,21 68.13% | -1,21 -1,20 -0.93% | -0,68 -1,47 53.5% | -0,83 -1,36 39.21% | -0,86 -1,52 43.38% | -0,92 -1,14 18.89% | -0,96 -1,03 7.46% | -1,04 | -1,20 | -1,36 |
|
Net income Million GBP | Released Forecast Spread | -1,30 -1,20 -8.68% | -2,19 -1,39 -57.53% | -0,70 -2,23 68.36% | -1,21 -1,20 -0.93% | -0,68 -1,47 53.5% | -0,83 -1,36 39.34% | -0,86 -1,52 43.53% | -0,92 -1,14 18.89% | -0,96 -1,03 7.46% | -1,04 | -1,20 | -1,36 |
|
EPS USD | Released Forecast Spread | -1,20 -1,10 -9.09% | -1,90 -1,20 -58.33% | -0,60 -1,80 66.67% | -1,00 -0,90 -11.11% | -0,60 -1,10 45.45% | -0,69 -1,13 38.94% | -0,69 -1,12 38.39% | -0,77 -0,87 11.49% | -0,78 -0,79 1.27% | -0,83 | -0,15 | -0,16 |
| Announcement Date | 12/05/22 | 11/08/22 | 09/11/22 | 22/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 21/03/24 | 09/05/24 | - | - | - |
More events
Past sector events for Xenetic Biosciences, Inc.
| Today | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-14 | CELCUITY INC.: Q1 2024 Earnings Release |
| 2024-05-13 | IMMATICS N.V.: Q1 2024 Earnings Release (Projected) |
| 2024-05-13 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-13 | PEPTIDREAM INC.: Q1 2024 Earnings Release |
| 2024-05-13 | NYKODE THERAPEUTICS: Q1 2024 Earnings Release |
| 2024-05-13 | ABL BIO INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-13 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-13 04:01 pm | ALLOGENE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-12 | PHARMAESSENTIA CORPORATION: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- XBIO Stock
- Calendar Xenetic Biosciences, Inc.